α-Klotho, hypoxia-inducible factor-2α, and oxidative stress in hemodialysis ‒ interactions with anemia, secondary hyperparathyroidism, and intradialytic hypotension
Open Access
- 30 September 2026
- journal article
- Published by University of Rzeszow in European Journal of Clinical and Experimental Medicine
- Vol. 24 (3) , 482-491
Abstract
Introduction and aim. End-stage renal disease (ESRD) is associated with oxidative stress (OS) and hormonal disturbances linked to anemia, secondary hyperparathyroidism (SHPT), and intradialytic hypotension (IDH). This study evaluated the expression of α-Klotho (α-KL) and hypoxia-inducible factor-2α (HIF-2α) together with OS markers in hemodialysis (HD) patients and explored their interrelationships and associations with anemia, SHPT, and IDH. Material and methods. Fifty HD patients and 50 healthy controls were evaluated for clinical and biochemical parameters, malondialdehyde (MDA), catalase (CAT) activity, and α-KL and HIF-2α expression. Correlation and network analyses were used to evaluate molecular interactions. Results. Anemia, SHPT, and IDH were identified in 72%, 44%, and 18% of HD patients, respectively. Compared with controls, HD patients demonstrated significantly higher MDA levels and lower α-KL and HIF-2α expression, and CAT activity (all p<0.001). MDA positively correlated with parathyroid hormone (PTH) (r=0.26, p<0.01) and IDH (r=0.37, p<0.001), but inversely with hemoglobin (Hb) (r=−0.24, p<0.02) and CAT activity (r=−0.36, p<0.001). Lower α-KL and HIF-2α expression levels, together with reduced CAT activity, correlated positively with Hb (r=0.27–0.71) and inversely with PTH (r=−0.27 to−0.62) and IDH (r=−0.40 to−0.92) (all p<0.01). Positive intercorrelations were additionally found among α-KL, HIF-2α, and CAT (r=0.21–0.38, all p<0.05). Conclusion. Reduced α-KL and HIF-2α expression together with altered OS markers were associated with anemia, SHPT, and IDH in HD patients. The close interrelationships observed among α-KL, HIF-2α, and OS markers may reflect an integrated molecular pattern linked to dialysis-related complications. Additional prospective studies are warranted to further elucidate these relationships.Keywords
This publication has 44 references indexed in Scilit:
- KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)Kidney International, 2026
- Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosisInternational Immunopharmacology, 2023
- Upstream and downstream regulators of Klotho expression in chronic kidney diseaseMetabolism, 2023
- Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantagesEuropean Journal of Pharmacology, 2021
- Prevalence and Disease Burden of Chronic Kidney Disease2019
- Obesity‐associated glomerular inflammation increases albuminuria without renal histological changesFEBS Open Bio, 2018
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)Kidney International Supplements, 2017
- Klotho and agingBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patientsBiomedicine & Pharmacotherapy, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008